Literature DB >> 3995215

Pharmacokinetic projections for isoxicam and piroxicam in old and young subjects.

A J Campbell, D G Ferry, I R Edwards.   

Abstract

A single-dose pharmacokinetic study to determine the effect of age on the disposition of isoxicam and piroxicam was carried out on a group of old and a group of young subjects. Although there was no significant difference with either drug in the mean elimination half-time between the group of young and the group of old subjects, there was considerable individual variation. Steady-state levels were calculated to be three times as high in subjects with slow clearance as in those with more rapid clearance. Three weeks would be required with either drug to achieve steady-state drug levels in those subjects with slow drug-clearance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3995215     DOI: 10.1093/rheumatology/24.2.176

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  4 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Pharmacokinetics of naproxen in elderly patients.

Authors:  R M McVerry; J Lethbridge; N Martin; S K Mukerjee; T Littler; R Tallis; R Sibeon; M L Orme
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism.

Authors:  Chang-Keun Cho; Pureum Kang; Hye-Jung Park; Eunvin Ko; Chou Yen Mu; Yun Jeong Lee; Chang-Ik Choi; Hyung Sik Kim; Choon-Gon Jang; Jung-Woo Bae; Seok-Yong Lee
Journal:  Arch Pharm Res       Date:  2022-05-31       Impact factor: 4.946

Review 4.  Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.

Authors:  K T Olkkola; A V Brunetto; M J Mattila
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.